Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.

× No keyword cloud information.

22 in total

1. Review of cariprazine in management of psychiatric illness.

Authors: Rebecca H Campbell; Michael Diduch; Kristen N Gardner; Christopher Thomas
Journal: Ment Health Clin Date: 2018-03-23

Review 2. Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder.

Authors: Jean-Michel Azorin; Nicolas Simon
Journal: Drugs Date: 2019-10 Impact factor: 9.546

Review 3. Brexpiprazole: A Review in Schizophrenia.

Authors: James E Frampton
Journal: Drugs Date: 2019-02 Impact factor: 9.546

Review 4. Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole.

Authors: Joshua S Frankel; Thomas L Schwartz
Journal: Ther Adv Psychopharmacol Date: 2016-10-17

Review 5. Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents.

Authors: George T Kannarkat; Stanley N Caroff; James F Morley
Journal: Tremor Other Hyperkinet Mov (N Y) Date: 2022-06-08

Review 6. Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Authors: Giuseppe Di Giovanni; Dubravka Svob Strac; Montse Sole; Mercedes Unzeta; Keith F Tipton; Dorotea Mück-Šeler; Irene Bolea; Laura Della Corte; Matea Nikolac Perkovic; Nela Pivac; Ilse J Smolders; Anna Stasiak; Wieslawa A Fogel; Philippe De Deurwaerdère
Journal: Front Neurosci Date: 2016-11-24 Impact factor: 4.677

The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out.

1. Review of cariprazine in management of psychiatric illness.

Review 2. Dopamine Receptor Partial Agonists for the Treatment of Bipolar Disorder.

Review 3. Brexpiprazole: A Review in Schizophrenia.

Review 4. Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole.

Review 5. Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents.

Review 6. Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

7. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity.

Review 8. Clinical role of brexpiprazole in depression and schizophrenia.

Review 9. Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future.

Review 10. Novel treatment options in depression and psychosis.